Skip to main content
Log in

PD 115,199: An antagonist ligand for adenosine A2 receptors

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

PD 115,199, N-[2-(dimethylamino)ethyl]-N-methyl-4- (2,3,6,7-tetrahydro-2,6-dioxo-1,3 -dipropyl-1H-purin-8-yl)benzenesulfonamide, was found to have high affinity for the A2 adenosine receptor labeled by 3H-NECA in rat striatal membranes (K i 15.5 nM). Unlike other potent adenosine antagonists, which always showed some degree of selectivity for the A1 receptor, PD 115,199 had equal affinity at A1 and A2 receptors (K i in 3H-CHA binding to A1 receptors 13.9 nM). 3H-PD 115,199 (126 Ci/mmol) was prepared by reduction of the diallyl analog, and binding experiments were performed with 0.5 nM 3H-PD 115,199 at 25°C in rat striatal membranes. By nonlinear least-squares analysis of the concentration-inhibition curve for the highly A1-selective adenosine antagonist PD 116,948 (8-cyclopentyl-1,3-dipropylxanthine), it could be demonstrated that about 11% of specific 3H-PD 115,199 binding was to A1 receptors, and the remainder to A2 receptors. A 20 nM concentration of PD 116,948 was included in subsequent experiments to eliminate the A1 component of binding. The remaining binding had a K d of 2.6 nM and B max of 56 pmol/g wet weight. Specific binding was about 79% of total binding. Affinities of compounds in the 3H-PD 115,199 assay were consistent with binding to a high-affinity A2 receptor: antagonists were consistently about three times more potent in 3H-PD 115,199 binding than in 3H-NECA binding, whereas agonists were consistently about fivefold less potent. Binding of 3H-PD 115,199 was much higher in striatum than in other brain regions, a distribution which is in agreement with the known localization of the high-affinity A2 receptor. No evidence of binding to the low-affinity A2 receptor was observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bristol TW, Badger EW (1984) Substituted 8-phenylxanthines. US Patent 4452788

  • Bruns RF (1980) Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can J Physiol Pharmacol 58:673–691

    Google Scholar 

  • Bruns RF, Daly JW, Snyder SH (1980) Adenosine receptors in brain membranes: Binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci USA 77:5547–5551

    Google Scholar 

  • Bruns RF, Lu GH, Pugsley TA (1985) Towards selective adenosine antagonists. In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: Receptors and modulation of cell functions. IRL Press, Oxford, pp 51–58

    Google Scholar 

  • Bruns RF, Lu GH, Pugsley TA (1986a) Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol 29:331–346

    Google Scholar 

  • Bruns RF, Fergus JH, Badger EW, Bristol JA, Santay LA, Hays SJ (1986b) PD 115,199: An antagonist ligand for adenosine A2 receptors. Fed Proc 45:801

    Google Scholar 

  • Bruns RF, Fergus JH, Badger EW, Bristol JA, Santay LA, Hartman JD, Hays SJ, Huang CC (1986c) Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 335:59–63

    Google Scholar 

  • Daly JW, Butts-Lamb P, Padgett W (1983) Subclasses of adenosine receptors in the central nervous system. Interaction with caffeine and related methylxanthines. Cell Mol Neurobiol 3:69–80

    Google Scholar 

  • Hamilton HW, Ortwine DF, Worth DF, Badger EW, Bristol JA, Bruns RF, Haleen SJ, Steffen RP (1985) Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application. J Med Chem 28:1071–1079

    Google Scholar 

  • Hamprecht B, van Calker D (1985) Nomenclature of adenosine receptors. Trends Pharmacol Sci 6:153–154

    Google Scholar 

  • Hampton RY, Medzihradsky F, Woods JH, Dahlstrom PJ (1982) Stereospecific binding of 3H-phencyclidine in brain membranes. Life Sci 30:2147–2154

    Google Scholar 

  • van Calker D, Müller M, Hamprecht B (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33:999–1005

    Google Scholar 

  • Yeung S-MH, Green RD (1984) [3H]5′-N-ethylcarboxamide adenosine binds to both Ra and Ri adenosine receptors in rat striatum. Naunyn-Schmiedeberg's Arch Pharmacol 325:218–225

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Send offprint requests to R. F. Bruns at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruns, R.F., Fergus, J.H., Badger, E.W. et al. PD 115,199: An antagonist ligand for adenosine A2 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 335, 64–69 (1987). https://doi.org/10.1007/BF00165038

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165038

Key words

Navigation